Skip to main content

Medtronic strategic deal with CathWorks could lead to $585 million buyout

As part of the agreement, Medtronic will invest up to $75 million in the Israeli med-tech company, which has developed a diagnostic system that helps doctors evaluate the severity of coronary artery disease.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.